{"id":782,"date":"2022-04-27T15:57:04","date_gmt":"2022-04-27T20:57:04","guid":{"rendered":"https:\/\/nuvaira.com\/references\/"},"modified":"2022-04-27T22:57:38","modified_gmt":"2022-04-27T22:57:38","slug":"references","status":"publish","type":"page","link":"https:\/\/nuvaira.com\/fr\/references\/","title":{"rendered":"R\u00e9f\u00e9rences"},"content":{"rendered":"
\n
\n
\n\n

R\u00e9f\u00e9rences<\/h1>\n \n \n \n \n\n <\/div>\n <\/div>\n<\/div>\n\n\n
\n
\n
\n\n
    \n
  1. \u00a0 Hummel <\/span>et al.<\/span><\/i> 2019 Physiologic and histopathologic effects of targeted lung denervation in an animal model. J Appl Physiol 126:67-76<\/span><\/li>\n
  2. \u00a0 Valipour<\/span> et al.<\/span><\/i> 2020 Two-year outcomes for the double-blind, randomized, sham-controlled study of targeted lung denervation in patients with moderate to severe COPD: AIRFLOW-2. Int J Chron Obstruct Pulmon 15:2807-2816<\/span><\/li>\n
  3. \u00a0 Pavord <\/span>et al.<\/span><\/i> 2017 Mepolizumab for eosinophilic chronic obstructive pulmonary disease. N Engl J Med 377(17): 1613-1629<\/span><\/li>\n
  4. \u00a0 Mayse <\/span>et al.<\/span><\/i> 2020 Targeted lung denervation in sheep: durability of denervation and long-term histologic effects on bronchial wall and peribronchial structures Respir. Res 21:117<\/span><\/li>\n
  5. \u00a0 Zhang <\/span>et al.<\/span><\/i> 2018 A systematic review of how patients value COPD outcomes. Eur Respir J 19;52(1)<\/span><\/li>\n
  6. \u00a0 Ihenacho <\/span>et al.<\/span><\/i> 2020 Economic burden of chronic obstructive pulmonary disease (COPD): A systematic literature review. Int J Chron Obstruct Pulmon Dis 26;15: 439-460<\/span><\/li>\n
  7. \u00a0 Dalal <\/span>et al.<\/span><\/i> 2011 Costs of COPD exacerbations in the emergency department and inpatient setting. Respir Med 105(3):454-60<\/span><\/li>\n
  8. \u00a0 Dalal <\/span>et al.<\/span><\/i> 2015 Impact of COPD exacerbation frequency on costs for a managed care population. J Manag Care Spec Pharm 21(7): 575-83<\/span><\/li>\n
  9. \u00a0 Patel <\/span>et al.<\/span><\/i> 2018 COPD affects worker productivity and health care costs. Int J COPD 13:2301-2311<\/span><\/li>\n
  10. Lipson <\/span>et al.<\/span><\/i> 2018 Once-daily single-inhaler versus dual therapy in patients with COPD. N Engl J Med 378(18): 1671-1680<\/span><\/li>\n
  11. Rabe <\/span>et al.<\/span><\/i> 2020 Triple inhaled therapy and two glucocorticoid doses in moderate-to-very severe COPD. N Engl J Med 383(1):35-48<\/span><\/li>\n
  12. Donaldson <\/span>et al.<\/span><\/i> 2002 Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease Thorax 57(10):847-52<\/span><\/li>\n
  13. Halpin <\/span>et al.<\/span><\/i> 2017 Effect of a single exacerbation on decline in lung function in COPD. Respir Med 128: 85-91\u00a0<\/span><\/li>\n
  14. Dransfield <\/span>et al.<\/span><\/i> 2017 Acute exacerbations and lung function loss in smokers with and without Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 195(3): 324-330<\/span><\/li>\n
  15. Seemungal <\/span>et al.<\/span><\/i> 1998 Effect of exacerbation on quality of life with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:1418-22<\/span><\/li>\n
  16. Westerik <\/span>et al.<\/span><\/i> 2017 Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD. Respir Res 18(1):31<\/span><\/li>\n
  17. Soler-Cataluna <\/span>et al.<\/span><\/i> 2005 Severa acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60(11):925-31<\/span><\/li>\n
  18. Rothnie <\/span>et al.<\/span><\/i> 2018 Natural history of chronic obstructive pulmonary disease exacerbations in a general practice-based population with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 198(4):464-471<\/span><\/li>\n
  19. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. 2021 Report<\/span><\/li>\n
  20. Hurst <\/span>et al.<\/span><\/i> 2020 Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life. Eur J Intern Med 73:1-6<\/span><\/li>\n
  21. Pison <\/span>et al.<\/span><\/i> 2021 Safety of denervation following targeted lung denervation therapy for COPD AIRFLOW-1 3-year outcomes. Respir Res 22(1): 62<\/span><\/li>\n
  22. Hartman JE, Conway F, Degano B, Augustijn SWS, Herth FJF, Mayr A, Chacaroun S, Tonkin J, Valipour A, Slebos DJ. Rate of lung function decline slows in the 3 years after targeted lung denervation in COPD. Respir Med 2021; 188: 106604<\/span><\/li>\n
  23. Khakban <\/span>et al.<\/span><\/i> 2017 The projected Epidemic of Chronic Obstructive Pulmonary Disease Hospitalizations over the Next 15 Years. A Population-based Perspective Am J Respir Crit Care Med 2016;195(3):1-5.<\/span><\/li>\n
  24. Canning BJ 2006 Reflex regulation of airway smooth muscle tone J Appl Physiol 101:971-985.\u00a0<\/span><\/li>\n
  25. Valipour A <\/span>et al.<\/span><\/i> 2018 Long-term safety of bilateral targeted lung denervation in patients with COPD Int J Chron Obstruct Pulmon Dis 13:2163-2172.<\/span><\/li>\n
  26. Valipour A <\/span>et al.<\/span><\/i> 2019 Safety and dose study of targeted lung denervation in moderate\/severe COPD patients Respiration 98:329-339.\u00a0<\/span><\/li>\n
  27. Slebos DJ <\/span>et al.<\/span><\/i> 2019 Safety and adverse events after targeted lung denervation for symptomatic moderate to severe chronic obstructive pulmonary disease (AIRFLOW). A multicenter randomized controlled clinical trial Am J Respir Crit Care 200:1477-1486.<\/span><\/li>\n<\/ol>\n

     <\/p>\n

    Les risques potentiels connus associ\u00e9s \u00e0 l\u2019intervention de DCP incluent, entre autres, une aggravation des sympt\u00f4mes de la BPCO (essoufflement, aggravation de la toux, exacerbations de la BPCO), une expectoration de mucus teint\u00e9 de sang, des difficult\u00e9s \u00e0 avaler, une douleur thoracique, des maux d\u2019estomac ou une sensation de sati\u00e9t\u00e9, des troubles gastriques et de la fi\u00e8vre.\u00a0<\/span><\/p>\n

     <\/p>\n

    Le syst\u00e8me de D\u00e9nervation des Poumons dNerva\u00ae est un dispositif en cours d\u2019\u00e9valuation aux \u00c9tats-Unis et dispose du marquage r\u00e9glementaire\u00a0CE. <\/span><\/p>\n<\/div>\n \n \n <\/div>\n<\/div>\n\n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-782","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nR\u00e9f\u00e9rences - Nuvaira<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nuvaira.com\/fr\/references\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R\u00e9f\u00e9rences - Nuvaira\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nuvaira.com\/fr\/references\/\" \/>\n<meta property=\"og:site_name\" content=\"Nuvaira\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-27T22:57:38+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/nuvaira.com\/fr\/references\/\",\"url\":\"https:\/\/nuvaira.com\/fr\/references\/\",\"name\":\"R\u00e9f\u00e9rences - Nuvaira\",\"isPartOf\":{\"@id\":\"https:\/\/nuvaira.com\/fr\/#website\"},\"datePublished\":\"2022-04-27T20:57:04+00:00\",\"dateModified\":\"2022-04-27T22:57:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/nuvaira.com\/fr\/references\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/nuvaira.com\/fr\/references\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/nuvaira.com\/fr\/references\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/nuvaira.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"R\u00e9f\u00e9rences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/nuvaira.com\/fr\/#website\",\"url\":\"https:\/\/nuvaira.com\/fr\/\",\"name\":\"Nuvaira\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/nuvaira.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"R\u00e9f\u00e9rences - Nuvaira","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nuvaira.com\/fr\/references\/","og_locale":"fr_FR","og_type":"article","og_title":"R\u00e9f\u00e9rences - Nuvaira","og_url":"https:\/\/nuvaira.com\/fr\/references\/","og_site_name":"Nuvaira","article_modified_time":"2022-04-27T22:57:38+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nuvaira.com\/fr\/references\/","url":"https:\/\/nuvaira.com\/fr\/references\/","name":"R\u00e9f\u00e9rences - Nuvaira","isPartOf":{"@id":"https:\/\/nuvaira.com\/fr\/#website"},"datePublished":"2022-04-27T20:57:04+00:00","dateModified":"2022-04-27T22:57:38+00:00","breadcrumb":{"@id":"https:\/\/nuvaira.com\/fr\/references\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nuvaira.com\/fr\/references\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nuvaira.com\/fr\/references\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nuvaira.com\/fr\/"},{"@type":"ListItem","position":2,"name":"R\u00e9f\u00e9rences"}]},{"@type":"WebSite","@id":"https:\/\/nuvaira.com\/fr\/#website","url":"https:\/\/nuvaira.com\/fr\/","name":"Nuvaira","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nuvaira.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/nuvaira.com\/fr\/wp-json\/wp\/v2\/pages\/782","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nuvaira.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/nuvaira.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/nuvaira.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nuvaira.com\/fr\/wp-json\/wp\/v2\/comments?post=782"}],"version-history":[{"count":0,"href":"https:\/\/nuvaira.com\/fr\/wp-json\/wp\/v2\/pages\/782\/revisions"}],"wp:attachment":[{"href":"https:\/\/nuvaira.com\/fr\/wp-json\/wp\/v2\/media?parent=782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}